We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 12,051

The Granston Memo in Action: DOJ Announces Intent to Seek Dismissal of FCA Complaints in Key Cases
  • Steptoe & Johnson LLP
  • USA
  • January 17 2019

In a motion filed in the US District Court for the Eastern District of Texas in late 2018, the US Department of Justice (DOJ) sought to dismiss 11


“Fake Meat” Discussed at Farm Bureau Federation Annual Meeting
  • Duane Morris LLP
  • USA
  • January 17 2019

The American Farm Bureau Federation (AFBF), a prominent non-governmental organization in the U.S. representing farm and ranch families, held its


In Case You Missed It: A List of Our Health Care Year in Review Posts
  • Mintz
  • USA
  • January 17 2019

Over the last few weeks, we published a number of posts examining important developments and trends in 2018 as well as what we expect to see in 2019


Ninth Circuit Affirms Federal Preemption Over Dietary Supplement Claims
  • Reed Smith LLP
  • USA
  • January 17 2019

We have taken a daily multivitamin ever since our doctor told us that we were chronically deficient in a particular vitamin, the one you can get from


FDA Resumes Inspections of High-Risk Food Facilities
  • Keller and Heckman LLP
  • USA
  • January 16 2019

As previously reported on this blog, the partial federal government shutdown stalled FDA’s ability to conduct routine inspections of domestic food


FDA Issues Guidance Documents on the “Deemed to be a License” Transition Provision of the BPCIA
  • Rothwell, Figg, Ernst & Manbeck, PC
  • USA
  • January 16 2019

The Biologics Price Competition and Innovation Act (“BPCIA”) requires applications to market a biological product be submitted for review by the FDA


FDA Proposes to Clarify and Formalize the De Novo Classification Process for Medical Devices
  • Epstein Becker Green
  • USA
  • January 16 2019

On December 7, 2018, the U.S. Food and Drug Administration (“FDA”) published a proposed rule (“Proposed Rule”) that, if finalized, would clarify the


Blumenauer Introduces the “Regulate Marijuana Like Alcohol Act”
  • Burns & Levinson LLP
  • USA
  • January 16 2019

As described in last week’s post, 2018 proved to be an exceptionally exciting year for the cannabis industry: five states approved legalization


Washington Healthcare Update- Jan 15, 2019
  • McGuireWoods Consulting LLC
  • USA
  • January 15 2019

This Week: As of today, the government has been partially shut down for 25 days, surpassing the longest federal government shutdown in history during


The Final Score: 2018 Drug & Biologic Patent Approvals
  • Dilworth IP
  • USA
  • January 15 2019

The past year was a big year for FDA approved new drugs and biologics - 59 in fact, compared to 46 in 2017 and a mere 22 in 2016. From the published